Calcium carbonate 680mg / Magnesium carbonate heavy 80mg chewable tablets
Available from pharmacies, supermarkets, and retail outlets
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Calcium carbonate + Magnesium carbonate
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
3 branded products available
Part of the Andrews brand family (generic: Calcium carbonate + Magnesium carbonate)
MHRA licensed products
View all licensed products for Calcium carbonate + Magnesium carbonate on the MHRA register
Rennie Peppermint chewable tablets
Rennie Spearmint chewable tablets
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(4)
Chronic kidney disease: assessment and management (NG203)
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (TA160)
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (TA161)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 21 studies.
Reviews & meta-analyses: 1 · 2018–2026
Showing all 21 studies, sorted by most relevant.
L. Mo, Yu Hao, Yunpeng Liu, et al.
Cement and Concrete Research, 2019
N. Rakhimova
Construction and Building Materials, 2022
Z. Molnár, I. Dódony, M. Pósfai
Geochimica et Cosmochimica Acta, 2023
Amorphous calcium carbonate (ACC) is known as a precursor to crystalline calcium carbonate polymorphs (CaCO3) in various natural and synthetic systems. While ACC has been shown to form by heterogeneous nucleation in biological systems, it is less obvious whether it plays any role in inorganic settings where carbonate minerals grow on pre-existing surfaces. Tight assemblies of calcium carbonate (CaCO3) phases and clay minerals occur in rock-forming quantities in marlstones, are abundant in Earth’s critical zone, in the sediments of aqueous environments, and in the atmosphere as aerosol particles. Previous studies suggested that the co-occurrence of clay and carbonate minerals (especially smectite and calcite) results from the heterogeneous nucleation of CaCO3 on the surface of smectite. In order to understand the role of ACC in the heterogeneous nucleation of carbonate minerals and the effects of common silicate mineral surfaces on the stability of ACC, we synthesized ACC both in the presence and absence of smectite, kaolinite, and quartz, monitored the pH of the solution during the experiments, and studied the precipitated phases with various transmission electron microscopy techniques. Since Mg2+ and (PO43−) ions are known to prolong the lifetime of ACC and are important components in natural aqueous environments, we tested their effects on ACC transformation in both homogeneous and heterogeneous systems. In all studied systems ACC was the first condensed carbonate phase. The presence of smectite in the solution reduced the lifetime of ACC and led to the rapid formation of calcite. We suggest that the main factor driving the transition was the enhanced growth of ACC particles on the surfaces of smectite flakes. On the other hand, the presence of kaolinite and quartz slightly increased ACC stability; ACC typically rimmed the silicate particles and transformed slower than separated, individual ACC particles. When Mg2+ was present in the solution, ACC stability significantly increased and led to the formation of aragonite instead of calcite in both homogeneous and heterogeneous systems. The presence of (PO4)3− ions caused only a minor delay in ACC transformation and the crystalline product was calcite, irrespective of the presence of silicate minerals. These observations suggest that smectite minerals play important roles in the formation of carbonate minerals by providing a suitable surface for the rapid growth and coalescence of ACC particles, leading to larger particle sizes which, in turn, result in the conversion of ACC into calcite.
Abstract licence: CC BY-NC-ND
A. Mapossa, E. G. R. dos Anjos, U. Sundararaj
Materials, 2024
This study investigates the effects of inorganic flame retardants, zinc borate, and magnesium hydroxide, on the thermal, morphological, flame retardancy, and mechanical properties of polypropylene (PP)/calcium carbonate composites for potential construction industry applications. Polypropylene/calcium carbonate (50 wt.%) composites containing 5 and 10 wt.% flame retardants were prepared using a batch mixer, followed by compression moulding. The results demonstrated enhanced thermal stability, with the highest char residue reaching 47.2% for polypropylene/calcium carbonate/zinc borate (10 wt.%)/magnesium hydroxide (10 wt.%) composite, a notably strong outcome. Additionally, the composite exhibited an elevated limited oxygen index (LOI) of 29.4%, indicating a synergistic effect between zinc borate and magnesium hydroxide. The proposed flame retardancy mechanism suggests that the flammability performance is driven by the interaction between the flame retardants within the polypropylene/calcium carbonate matrix. Magnesium hydroxide contributes to smoke suppression by releasing water, while zinc borate forms a protective glassy foam that covers the burning surface, promoting char formation and acting as a physical barrier to heat transmission and fire spread. Scanning electron microscopy confirmed good dispersion of the additives alongside calcium carbonate within the polymer matrix. Despite the addition of up to 10 wt.% flame retardants, the composites maintained high-notched impact strength.
Abstract licence: CC BY
Jiawen Wang, Z. Cheng, Duanjing Chen, et al.
Journal of the mechanical behavior of biomedical materials, 2023
- Bone Cements
- Calcium Carbonate
- Bone Regeneration
B. Purgstaller, Katja E. Goetschl, V. Mavromatis, et al.
Crystengcomm, 2018
) shift from Ca (-6.28 ± 0.05) to Mg (-4.54 ± 0.16) ACMC endmember, can be explained by the increasing water content and changes in short-range order, as Ca is substituted by Mg in the ACMC structure. The results of this study shed light on the factors controlling ACMC solubility and its temporal stability in aqueous solutions.
Abstract licence: CC BY-NC
Tianxiao Wang, Panpan Li, Yunting Guo, et al.
Journal of Magnesium and Alloys, 2025
• Biomimetic deposited calcium carbonate coating was treated by sodium stearate. • Corrosion current density dropped 3 orders after treatment, with improved resistance. • Cell viability increased by 20% after treatment, showing a better biocompatibility. Magnesium alloy is a promising biodegradable metal material for hard tissue engineering. However, its high corrosion rate limits its application. In our previous study, we biomimetically deposited a calcium carbonate coating on the surface of magnesium alloy using siloxane induction. This calcium carbonate coating demonstrated excellent in vitro biocompatibility and provided partial protection for the magnesium alloy substrate. In this study, we further enhanced the corrosion resistance of the calcium carbonate coating by treating it with stearic acid and its derivative, sodium stearate. Electrochemical corrosion tests revealed that the sodium stearate-treated calcium carbonate coating reduced the corrosion rate by two orders of magnitude. Additionally, in vitro biocompatibility assessments showed that while the biocompatibility of the sodium stearate-treated coating was slightly reduced, it remained acceptable compared to the magnesium substrate. This study builds on our previous work and offers a promising reinforcement strategy for degradable magnesium alloys in medical applications.
Abstract licence: CC BY-NC-ND
Hui Zhao, Yong Han, Mengyi Liang, et al.
Minerals, 2023
The discovery of cyanobacteria fossils in microbialite prompts the investigation of carbonate biomineralization using cyanobacteria. However, the impact of coexisting magnesium and iron in microbialite on carbonate biomineralization has been overlooked. Here, Synechocystis sp. PCC 6803 was used to induce calcium carbonate in the presence of coexisting magnesium and ferric ions. The findings demonstrate that cell concentration, pH, carbonic anhydrase activity, and carbonate and bicarbonate concentrations decreased with increasing concentrations of magnesium and calcium ions. Ferric ions yielded a contrasting effect. The levels of deoxyribonucleic acid, protein, polysaccharides, and humic substances in extracellular polymeric substances increased in the presence of separated or coexisting calcium, magnesium, and ferric ions. Magnesium ions inhibited calcium ion precipitation, whereas ferric ions exhibited the opposite effect. Protein secondary structures became more abundant and O-C=O and N-C=O contents increased with increasing ion concentrations by Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy analyses. Scanning electron microscopy revealed that ferric ions lead to rougher surfaces and incomplete rhombohedral structures of calcite, whereas magnesium ions promoted greater diversity in morphology. Magnesium ions enhanced the incorporation of ferric ions. This work aims to further understand the effect of magnesium and ferric ions on calcium carbonate biomineralization induced by cyanobacteria.
Abstract licence: CC BY
Boers JRM, Garcia M, Sanchez E, et al.
2026
- Calcium Carbonate
- Labor, Induced
- Oxytocics
Al-Hamzah AA, Fellows CM, Al-Bishri M, et al.
2026
Maintaining the concentration of magnesium in potable water above minimum levels has been suggested to have public health benefits. A twelve-month trial of attempting this goal by partial replacement of limestone with dolomite in eight out of twenty-six post-treatment contactors at the Ras al Khair seawater desalination plant, the largest such plant in Saudi Arabia with a daily production of over 1,000,000 m3 of desalinated water. Over the course of the trial increases in Mg concentration in the range 1 to 2 ppm were achieved without necessitating increases in carbon dioxide utilization or any reduction in production volume. Alkalinity, calcium, and total dissolved solids remained within acceptable parameters. Calculated supersaturation values suggest strongly that it will not be possible to increase concentrations significantly further at the pH and temperature conditions of the study. Thus, while use of dolomite to this extent is a very low-cost strategy for magnesium supplementation, its scope of application without additional carbon dioxide consumption and capital investment is limited. The ratio of magnesium to chloride in SWRO product water was estimated in the course of the study and was found to be approximately half of the ratio in Standard Seawater, suggesting that under operational conditions (giving 1500 mg/L from first pass reverse osmosis) rejection of magnesium was significantly greater than rejection of sodium.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.